What is VVOS's dilution risk score?

VVOS has a latest available DilutionScore record of 78/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for VVOS, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for VVOS?

DilutionWatch tracks 25 SEC filing types for VVOS including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect VVOS shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For VVOS, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for VVOS tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for VVOS. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

VVOS Dilution Risk Score: 78/100 (CRITICAL)

Score Breakdown

📋 Offering Ability

80

💰 Cash Runway

95

📊 Float Risk

40

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 54%

🔄 Reverse Split model est. 70%

• 50-day avg $0.94 below $1 exchange minimum

• Only 1 months cash — financial pressure

💰 Capital Raise model 55%

• Critical: only 1.3 months cash remaining

📉 Score Deterioration model 15%

• Score already CRITICAL (78/100) — events likely imminent

🔔 Track VVOS — Get forecast alerts →

Market Data

Market Cap$9.73M

Shares Outstanding20.12M

Float12.05M

Cash$1.77M

Debt$8.14M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 177.0% shares (2026Q1 vs prior)

25 institutional holders · 1.82M shares

#1 ARMISTICE CAPITAL, LLC 1.12M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 273.3K shares

#3 GEODE CAPITAL MANAGEMENT, LLC 95.5K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.20M

Days to Cover7.8

% of Float10.0%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2025-12-31

8-K 8K EVENT 2026-04-22

3 FORM3 2026-04-10

8-K 8K EVENT 2026-04-03

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual VVOS Dilution Snapshot

Vivos Therapeutics, Inc. (VVOS) has a DilutionScore of 78/100, rated Critical dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for VVOS: 8-K on 2026-04-22; 3 on 2026-04-10; 8-K on 2026-04-03.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.